Clinical trial · Interventional
Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma
A Randomized Controlled Clinical Trial of Cytokine-induced Killer (CIK) Cells Treatment in Patients With Refractory Non-Hodgkin Lymphoma
NCT02497898CI-TRIAL-00018552not yet recruitingPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to study the safety and efficacy of chemotherapy usage followed by CIK transfusion in refractory and/or chemoresistant lymphomas.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphoma, Non-Hodgkin | Non-Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cytokine-induced killer cells (CIK) | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- regular chemotherapy
- description
- Patients after chemotherapy are just followed up.
- type
- EXPERIMENTAL
- label
- CIK regimen
- description
- Patients after chemotherapy will receive at least 3 cycles of Cytokine-induced killer cells (CIK) treatment every 3 months.
- interventionNames
- Biological: Cytokine-induced killer cells (CIK)
Primary outcomes (1)
- measure
- Progression-Free-Survival (PFS)
- timeFrame
- 1 month
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * diagnosed as non-Hodgkin lymphoma with negative effect of regular chemotherapy, and need further therapy Exclusion Criteria: * patients refuse the therapy or have no tolerance for the therapy
References
Publications (0)
Data not yet available
No reference posted for this study.